The prevalence of advanced precancerous polyps and colorectal cancer among adults aged 45 to 49 years undergoing initial ...

ABSTRACT: Breast metastasis from gastrointestinal cancers is uncommon, accounting for 0.5% to 2% of breast cancer cases. The clinical and radiological manifestations may resemble those of primary ...

This report describes the patient’s clinical presentation, diagnostic workup, and management, as well as a review of current literature. The aim of this case report is to highlight a rare clinical ...

Even though rectal bleeding is alarming, doctors say patients are ashamed to mention it, delaying colon cancer diagnosis and treatment.

To better understand the optimal approach for these patients, Lai and colleagues analyzed data from 3792 individuals undergoing curative resection for locally advanced rectal cancer between ...

More: What is prostate cancer?What to know after Joe Biden's diagnosis “Someone like the president you would presume was still having their PSA blood test and the digital rectal exam on an ...

Casual walking and chores can lower cancer risk, says Oxford research, as 9,000 steps daily cut risk by 16%, supporting physical activity guidelines. Fox News Media Fox Business ...

Rectal cancer kills around 4,100 people in the UK (around 410 in Scotland) every year. Over the last 20 years, the incidence of early-onset rectal cancer has increased by 50.5% in the UK (53.6% in ...

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery and other types of more invasive treatment to cure their disease.

Vienna, Austria – Rectal cancer is a type of bowel cancer that develops in the last several centimetres of the large intestine, just before the anus. It’s one of the most common cancers in ...

The immunotherapy protocol successfully treated 100% of rectal cancer patients involved in the trial. “My husband, Tommy, and I were preparing for the worst,” recalled Maureen Sideris, ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, offering patients an alternative to chemotherapy and surgery.